Skip to main content

AACE 2023 Main banner

Tweets by AACE 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

On-Demand Video

Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)

NAFLD and Type 2 Diabetes: A Mutually Detrimental Relationship

Thursday, May 4, 2023

1:30 PM – 2:15 PM

Location: The AACE Talk Show - Room 347-348 - Summit Building - Level 3

CME/CE/MOC Credit

On-Demand Available For This Session

Speaker(s)

Scott D. Isaacs, MD, FACP, FACE

Adjunct Assistant Professor of Medicine
Emory University School of Medicine
Atlanta, Georgia, United States

PDF Slides
Blanca Lizaola-Mayo, MD

Arizona, United States

PDF Slides
Ken Cusi, MD, FACE, FACP

Chief of the Division of Endocrinology
University of Florida
Newberry, Florida, United States

PDF Slides

Moderator(s)

Rifka C. Schulman-Rosenbaum, MD, FACE, FACP (she/her/hers)

Professor of Medicine, Director of Inpatient Diabetes
Long Island Jewish Medical Center, Northwell Health
New Hyde Park, New York, United States

This session is supported by an educational grant by Novo Nordisk

Learning Objectives:

Describe the epidemiology, pathophysiology and natural history of NAFLD as the hepatic manifestation of type 2 diabetes and the metabolic syndrome.
Compare non-invasive testing modalities to detect patients at risk for clinically significant liver fibrosis.
Summarize the latest management recommendations from the AACE NAFLD Clinical Practice Guidelines.